Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Дедов И. И., Семичева Т. В., Петеркова В. А. Половое развитие: норма и патология. М. изд. Колор Ит Студио, 2002: 67-69
  2. Дедов И.И., Петеркова В.А., /Руководство по детско й эндокринологии/ Москва. Универсум паблишинг. 200бг:
  3. Carel JC, Eugster ЕА, Rogol А, Ghizzoni L, Palmert MR, Antoniazzi F, et al.; ESPE-LWPES GnRH Analogs Consensus Conference Group. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr; 123(4):75262.
  4. Marshall WА, Tanner JM. Variations in the pattem of pubertal changes in boys. Arch Dis Child. 1970 Feb;45(239):13-23.
  5. Chen М, Eugster ЕА. Central Precocious Puberty: Update on Diagnosis and Treatrnent . Paediatr Drugs. 2015 Aug; l 7(4):273-81. doi: 10.1007 /s40272-015-0 130-8
  6. Partsch CJ, Japing 1, Siebert R, Gosch А, Wessel А, Sippell WG, Pankau R. Central precocious puberty in girls with Williarns syndrome. J Pediatr. 2002 Sep; l 41(3):44 l -4.
  7. Temple IK, Cockwell А, Hassold Т, Pettay D, Jacobs Р. Matemal uniparental disomy for chromosome 14.J Med Genet. 1991 Aug;28(8):5 l l-4.
  8. Ioannides У, Lokulo-Sodipe К, Mackay DJ, Davies JH, Temple IK. Temple syndrome: improving the recognition of an underdiagnosed chromosome 14 imprinting disorder: an analysis of 51 puЬlished cases. J Med Genet. 2014 Aug;51(8):495-501. doi: 10.l 136/jmedgenet-20 14-102396. Epub 2014 Jun 2.
  9. Wakeling EL, Brioude F, Lokulo-Sodipe О, O'Connell SM, Salem J, Bliek J, Canton АР, Chrzanowska КН, Davies JH, Dias RP, Dubem В, Elbracht М, GiaЬicani Е, Grirnberg А, Gп,nskov К, Hokken-Koelega АС, Jorge АА, Kagarni М, Linglart А, Maghnie М, Mohnike К, Monk D, Moore GE, Murray PG, Ogata Т, Petit 10, Russo S, Said Е, Toumba М, Turner Z, Binder G, Eggermann Т, HarЬison MD, Ternple IK, Mackay DJ, Netchine 1. Diagnosis and management of Silver-Russell syndrome: first intemational consensus statement. Nat Rev Endocrinol. 2017 Feb;13(2):105-124. doi: 10.1038 /nrendo.2016.138. Epub 2016 Sep 2.
  10. 1О. Berberoglu М. Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management. J Clin Res Pediatr Endocrinol. 2009;1(4):164-74. doi: 10.4274 /jcrpe.vl i4.3. Epub 2009 Мау 2. DO1: 10.42 74/jc rpe.v l i4.3
  11. Haddad NG, Eugster ЕА. Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes. Best Pract Res Clin Endocrinol Metab. 2019 Jun;33(3):101273. doi: 10.1016 /j.beem.2019.04.007. Epub 2019 Apr 13.
  12. Rousse au-Merc k MF, Mis rahi М, Atger М, et al. Localization of the human luteini zing l10rmone/choriogonadotropin receptor gene (LHCGR) to chromosome 2р21. Cytogenet Cell Genet 1990;54(1е2):77е9.
  13. 13 . Shenker А, Laue L, Kosugi S, et al. А constitutively activating mutation of the luteini zing hormone receptor in familial male precocious pube rty. Nature 1993 ;365(6447):652е4 .
  14. Weinstein L.S. et а!. Activating mutation s of the stimulato ry G pro tein in the McCune-Albright syndrome // N. Engl. J. Med. 199 1. Vol. 325, № 24. Р. 16881695.
  15. Svoboda Р. et al. Biochemistry oftransmembrane signaling mediated Ьу trimeric G proteins // Physiol. Res. 2004. Vol. 53 Suppl 1. Р. S14l-152.
  16. Dumitrescu СЕ, Co llins МТ. McCune-Albright syndrome. Orphanet J Rare Dis. 2008;3:12 .
  17. Co llin s МТ, Singer FR, Eugs ter Е. McC une-Albri ght syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis. 2012;7(1):l-14.Brown R.J., Kelly М.Н., Collins М.Т. Cushing s yndrome in the McCune-Alb right syndrome // J. Clin. Endoc rinol. Metab. 2010. Vol. 95, № 4. Р. 15 081515.
  18. 1 8 . Co utant R, Lumbroso S, Re y R, Lahlou N, Venara М, Rouleau S, et al. Macroorchidism due to auto nomous hyperfunction of Sertoli cel\s and G(s)alph a gene mutation: an unusual expression of McCuneAlbright syndrome in а prepubertal Ьоу. J Clin Endocrinol Metab. 200 l Apr;86(4):1778 8 1.
  19. Sinnecker G, Willig RP, Stahnke N, Braendle W. Precocious pseudopuberty associated with multiple ovarian follicular cysts and low plasma oestradiol concentrations. Eur J Pediatr. 1989 Jun;148(7):6002.
  20. Pienkowski С, Ca rtault А, Carfagna L, Emoult Р, Vial J, Lem asso n F, Le Mandat А, Galinie r Р, Tauber М.. Ovarian cysts in prepubertal girls. Endocr Dev. 2012;22: lО1111 . doi: 10. l 159/000326627 . Epub 2012 Ju l 25
  21. De hner LP: Gonadal and extragonadal germ cell neoplas ia of c hildhood. Hum Pathol 14 (6): 493-511, 1983
  22. Mc Lachlan RI, O'Do nnell L, Meachem SJ, Stanton PG, de Кretser ОМ, Pratis К, et al. Identification of specific sites of hormonal regulation in spermatoge nesis in rats, monkeys, and man. Recent Prog Honn Res. (2002) 57:14979. doi: 10.12 10/rp.57.1.149
  23. Kubo О, Yamasaki N, Kamijo У, Amano К, Кitamura К, Demura R. Human chorionic gonadotropin produced Ьу ectopic pinealoma in а girl with precocious puberty. Ca se report. J Neurosurg. 1977 J u\;47( 1):10 1-5.
  24. Kitanaka С, Matsutani М, Sora S, Кitanaka S, Tanae А, Hibi I. Precocious puberty in а girl with an hCG-secretiпg s uprase lla r imm ature teratoma. Case report. J Neuro s urg. 19 9 4 Oct ;8 l (4):601-4.
  25. Anasti JN, Flack MR, Froehlich J, Nelson LM, Nisula ВС. А potential novel mechanism for precocious puberty injuvenile hypothyroidism. J Clin Endocrinol Metab. 1995 Jan;80( l ):276-9.
  26. Van Wyk JJ, Grumbach ММ. Syndrome ofprecocious menstruation and galactoпhea injuvenile hypothyroidis111. An exa111ple of honnonal overlap in pituitary feedback. J Pediatr. 1960 ;57:4 16 35
  27. Fuqua JS. Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab. 2013 Jun;98(6):2198-207. doi: 10.1210/jc.2013-1024
  28. Mills JL, Stolley PD, Davies J, Moshang Т Jr. Premature thelarche: natural history and etiologic investigation. Am J Dis Child 1981;135:743-5.
  29. de Vries L, Guz-Mark А, Lazar L, Reches А, Phillip М. Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty. J Pediatr. 2010 Mar; l 56(3):466-71. doi: 10.1016 /j.jpeds.2009.09.071.
  30. Novello L, Speiser PW. Premature Adrenarche. Pediatr Ann. 2018 Jan l;47(1):e7-el 1. doi: 1О.3928 /19382359-2017 1214-04.
  31. Teilmann G1, Pedersen СВ, Jensen ТК, Skakkebaek NE, Juul А. Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based оп national registries. Pediatrics. 2005 Dec;l 16(6):1323-8.
  32. Jung Н, Ojeda SR. Pathogenesis of precocious puberty in hypothalamic hamartoma. Hormone Research. 2002;57(2, supplement):3134. doi: 1O. l l 59/000058097.
  33. Valdueza JM, Cristante L, Dammann О, Bentele К, Vortmeyer А, Saeger W, Padberg В, Freitag J, Heпmann НО, Hoffman HJ, Fahlbusch R. Hypothalamic hamartomas: with special reference to gelastic epilepsy and surgery. Neurosurgery. 1994;34(6):949958. doi: 1O. l 227 /00006 123 l 994060000000l
  34. Gjikopulli А, Kollcaku L, Grimci L, Tako А, Bushati А, Dedo В, et al. Р32 2702: Hypothalamic hamartoma, gelastic epilepsy and precocious puberty. Eur J Paediatr Neurol. 2015 Мау l; 19:S103.
  35. Stephen MD, Zage РЕ, Waguespack SG. Gonadotropin-Dependent Precocious Puberty: Neoplastic Causes and Endocrine Considerations. Int J Pediatr Endoc rinol.;2011 ( 1):184502.
  36. Wood L.D. et al. Patients with McCune-Albright syndrome have а broad spectrum of abnormalities in the gastrointestinal tract and pancreas // Virchows Arch. Int. J. Pathol. 2017. Vol. 470, № 4. Р. 391400.
  37. Burke АВ, Collins МТ, Воусе АМ. Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis. 2017 Sep;23(6):697-708. doi: lO.l l l 1/odi.12563. Epub 2016 Sep l.
  38. Robinson С, Collins МТ, Воусе АМ. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives. Сuп Osteoporos Rep. 2016 Oct;14(5):178-86.
  39. Kim I, Kim ER, Nam HJ, Chin МО, Moon УН, Oh MR, Уео UC, Song SM, Kim JS, Uhm MR, Beck NS, Jin DK. Activating mutation of Gsa in McCune-Albright syndrome causes skin pigmentation Ьу tyrosinase gene activation on affected melanocytes. Horm Res. 1999;52:235-240. doi: 10. l l 59/000023467.
  40. Imel ЕА, Econs MJ. Fibrous dysplasia, phosphate wasting and fibroЫast growth factor 23. Pediatr Endocrinol Rev PER. 2007 Aug;4 Suppl 4:434-9.
  41. Foster СМ, Ross JL, Shawker Т, Pescovitz ОН, Loriaux DL, Cutler GB Jr, et al. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. J Clin Endocrinol Metab. (1984) 58:1161-5. doi: 10.1210 /jcem-58-6-1161
  42. Rivarola null, Belgorosky А, Mendilaharzu Н, Vidal G. Precocious puberty in children with tumours of the suprasellar and pineal areas: organic central precocious puberty. Acta Paediatr Oslo Nor 1992. 2001 Jul;90(7):751-6.
  43. DeSalvo DJ, Mehra R, Vaidyanathan Р, Kap\owitz РВ. In children with premature adrenarche, bone age advancement Ьу 2 or more years is common and generally benign. J Pediatr Endocrinol Metab. 2013;26(3-4):215-21. doi: 10.1515 /jpem-2012-0283.
  44. Van Winter JT, Noller KL, Zimmennan О & Melton LJ. Natural history of premature thelarche in Olmsted County, Minnesota, 1940 to 1984. Journal of Pediatrics 1990 116 278290.
  45. de Vries L, Horev G, Schwartz М, Phillip М. Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche. Eur J Endocrinol. 2006 Jun;154(6):891-8.
  46. Millar ОМ, Blake JM, Stringer DA, Hara Н, Babiak С. Prepubertal ovarian cyst formation: 5 years' experience. Obstet Gynecol. 1993;81:434-4 38
  47. de Sousa G, Wunsch R, Andler W. Precocious pseudopuberty due to autonomous ovarian cysts: а report of ten cases and long-term follow-up. Hormones (Athens) 2008;7:170-174.
  48. Papanikolaou А, Michala L. Autonomous Ovarian Cysts in Prepubertal Girls. How Aggressive Should We Ве? А Review ofthe Literature. J Pediatr Adolesc Gynecol. 2015 Oct;28(5):292-6.
  49. Papadimitriou А, Beri О, Tsialla А, Fretzayas А, Psychou F, Nicolaidou Р. Early growth acce\eration in girls with idiopathic, precocious puberty. J Pediatr. 2006;149(1):43-46
  50. Fontoura М, Brauner R, Prevot С, Rappaport R. Precocious puberty in girls: early diagnosis of а slowly progressing variant. Arch Dis Child. 1989;64(8):1170-1176
  51. Ladjouze А, Soskin S, Garel С, Jullien М, Naud-Saudreau С, Pinto G, Czemichow Р, Leger J. GH deficiency with central precocious puberty: а new rare disorder associated with а developmental defect ofthe hypothalamic-pituitary area. Eur J Endocrinol. 2007 Apr;l56(4):463-9.
  52. Cistemino М, Arrigo Т, Pasquino АМ, et а\. Etiology and age incid ence of precocio us puberty in gir ls: а multicentric study. J Pediatr Endocrinol Metab. 2000;13(suppl 1):695 701
  53. . Wendt S, Shelso J, Wright К, Furman W. Neoplastic Causes of Abnormal Puberty. Pediatr Blood Cancer. 2014 Apr;61(4):664.
  54. Marshall WA, Tanner JM (February 1970). "Variations in the pattem of pubertal changes in boys". Arch. Ois. Child. 45 (239): 13 23. doi:1O. l l 36/adc.45.239.13.
  55. Marshall WA, Tanner JM (June 1969). "Variations in pattem of pubertal changes in girls". Arch. Ois. Child. 44 (235): 291303 . doi:10.l 136 /adc.44.235.291.
  56. Neely ЕК, Hintz RL, Wilso n ОМ, et al. Norrnal ranges for imrnunochemiluminometric gonadot ropin assays. J Pediatr. 1995; 127(1):40 -4 6
  57. Neely ЕК, Wilson ОМ, Lee РА, Stene М, Hintz RL. Spontaneous serum gonadotro pin concentr ations in the evaluation ofprecocious puberty. J Pediatr. 1995 ;1 27(1):4752
  58. Ho uk СР, Kunselman AR, Lee РА. Adequacy of а single unstimulated luteini zing horrnone leve l to diagnose central precocious puberty in girls. Pediatrics. 2009 Jun; 123(6):е1059 63.
  59. Resende ЕА, Lara ВН, Reis JO, Ferreira ВР, Pereira GA, Borges MF. Assessment of basal and gonadotropin-releas ing hormone-stimulated gonadotropins Ьу immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab. 2007;92(4):14241429
  60. Вау К, Andersson АМ, Skakkebaek NE. Estradiol levels in prepubertal boys and girls: analytical challenges. Int J Androl. 2004;27(5):266273
  61. Harrington J, Palm ert MR, Hamilton J. Use of local data to enhance uptake of puЬlish ed recommendations: ал example from the diagnostic evaluation of precocious puberty. Arch Ois Child. 2014 Jал;99(1):1520.
  62. Lee O-М, Chung I-H. Moming basal luteinizing hormone, а good screening tool for diagnosing central precocious puberty. Ann Pediatr Endocrinol Metab. 2019 Mar;24(1 ):2733.
  63. Bangalore Кrishna К, Fuqua JS, Rogol АО, Кlein КО, Popovic J, Houk СР, et а\. Use of Gonadotropin-Releasing Ho rmone Analogs in Children: Update Ьу an Intemational Consortium. Horm Res Paediatr. 2019;9 1(6):35 772.
  64. Kuiri-Hiinninen Т, Sanki lampi U, Ounkel L. Acti vation of the Hypothalamic-P ituitary-Gonadal Axis in Infancy : Minipuberty. Horm Res Paediatr. 20l 4;82(2) :7380.
  65. Bizzarri С, Spadoni GL, Bottaro G, Monta nari G, Giannone G, Сарра М, et al. The response to gonadotro pin releas ing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years ofl ife. J Clin Endocrinol Metab. 2014 Feb;99(2):4339.
  66. Pescovitz ОН, Hench KD, Bames КМ, Loriaux DL, Cutler GB Jr. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab. 1988 ;67(3):474-4 79
  67. Oerter К Е, Uriarte ММ, Rose SR, Bames КМ, Cutler GB Jr. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab. 1990 ;71 (5):1251 1258
  68. Neely ЕК, Hintz RL, Wilson DM, Lee РА, Gautier Т, Argente J, et al. Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr. 1995 ;127(1):40-6 .
  69. Brito VN, Batista МС, Borges MF, Latronico АС, Kohek МВ, Thirone АС, et al. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab. 1999 ;84( 10):3539-44.
  70. Brito VN, Latronico АС, Arnhold IJ, Mendonca ВВ. А single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls. J Clin Endocrinol Metab. 2004;89(9):4338-42.
  71. Pastemak У, Friger М, Loewenthal N, Haim А, Hershkovitz Е. The utility ofbasal serum LH in prediction of central precocious puberty in girls. Eur J Endocrinol. 2012;166:295-9.
  72. Sathasivam А, Garibaldi L, Shapiro S, Godbold J, Rapaport R. Leuprolide stimulation testing for the evaluation of early female sexual maturation. Clin Endocrinol (Oxt). 2010;73(3):375 -8 1.
  73. 73 . Lee DS, Ryoo NY, Lee SH, Kim S, Kim JH. Basal luteini zing hoпnone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls? Ann Pediatr Endocrinol Metab. 2013;18:196-20 1.
  74. Freire АУ, Escobar МЕ, Gryngarten MG, Arcari AJ, Ballerini MG, Bergada 1, et а!. High diagnostic accuracy of subcutaneous triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls. Clin Endocrinol (Oxt). 2013;78(3):398-404.
  75. Ecke rt, K.L., Wilson, D.M., Bac hrach, L.K., Anhalt, Н., Habiby, R.L., Olney, R.C., Hintz, R.L. & Neely, Е.К . (l 996) А single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty. Pediatrics, 97, 517-519.
  76. Roger М, Lahlou N, Chaussain JL. Gonadotropin-releasing hormone testing in pediatrics. ln: Ranke МВ, ed. Diagnostics of Endocrine Function in Children and Adolescents. Heidelberg, Germany: Johann Ambrosius Barth; 1996:346 369
  77. Wilson DA, Hofman PL, Miles HL, Unwin КЕ, McGrail С Е, Cutfield WS. Evaluation ofthe buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty. J Pediatr. 2006 Jan;148(1):89-94. doi: 10.10 16/j.jp eds.2005.08.045. PMID: 16423605.
  78. Prasad НК, Кhadilkar VV, Jahagirdar R, Кhadilkar АУ, Lalwani SK. Evaluat io n of GnRН analogue testing in diagnosis and management of children with pubertal diso rder s. Indian J Endocrinol Metab. 2012 Мау;16(3):400-5 . d oi: 10.4 103 /2230-8210.95682. PMID: 22629507; PMCID: РМС335484 8.
  79. Болмасова А.В" Оптимизация ростового прогноза у детей с rонадот ропи нзависимыми формами преж девременного полового развития опухолевого и неопухолевоrо гене за : автореферат дис. ... кандидата медицинских наук : 14.01.02 / Болмасова Анна Викторо вна; [Место защит ы: Эндокрин. науч. центр].Москва, 2012.26 с.: ил. РГБ ОД, 9 12-1 /2667
  80. Chudecka-Glaz А, Rzepka-G6rska 1, Kosmowska В, Glaz С. [The level s of selected hormones in serum and ovarian cyst fluid in girls and young women]. Ginekol Pol. 1999 Мау;70(5):236-4 1.
  81. Padilla SL. Androgen-producing tumors in children and adolescents. Adolesc Pediatr Gynecol. 1989 Jun 1;2(3):135-42.
  82. Englun d АТ, Geffner МЕ, Nagel RA, Lippe ВМ, Braunstein GD. Pediatric germ cell and human cl10rionic gonadotropin-producing tumors. Clinical and laboratory features. Ат J Dis Child. 1991 Nov; l 45 ( 1 l ):1294-7 .
  83. . Armengaud J-B, Charkaluk M-L, Trivin С, Tardy V, Breart G, Brauner R, et al. Precoc ious pubarche: distinguishing la te-onset congenital adrenal hyperplasia from premature adrenarche . J Clin Endocrinol Metab. 2009 Aug;94(8):2835-40.
  84. Livadas S, Dracopoulou М, Dastamani А, Sertedaki А, Maniati-Christidi М, Magiakou А-М, et al. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused Ьу mutations of the СУР21А2 gene. Clin Endocrinol (Oxf). 2015 Apr;82(4):543-9.
  85. Razavi Z.*, RastgooH aghi А. Precocio us Puberty Associated with an Adrenal Tumor: А case report/ Iran J Ped Hematol Oncol. 2016, Vol6.No2, 136141
  86. Goyal А, Malhotra R, Кhadgawat R Precocious pseudopube rty due to virilising adrenocortical carcinoma progressing to ceпtral precocious puberty afteг surgery BMJ Case Reports СР 2019;12:е229476.
  87. Kafi SE, Alagha Е, Shazly МА, AIAgha А. Pseudo-precocious Pubeгty Associated with an Adrenocortical Tшnor iп а Young Child. Cureus. 2019;11(12):е6440. PuЬ\ished 2019 Dec 22. doi:1О.7759/cuгeus.6440
  88. Comite F, Schiebiпger RJ, Albe rtsoп ВО, Cassorla FG, Vandeг Ven К, Cullen TF, Loriaux DL, Cutleг GB Jг. lsosex ual precocioнs pseudopuberty secoпdary to а feminizing adrenal tumor. J Clin Endocrinol Metab. 1984 Mar;58(3):435-40. doi: 10.1 210/jcem-58-3-435. PMID : 6693544 .
  89. Tanner JM, Whitehouse RH, Marshall WA, et al.: Assessment of Skeletal Matнrity and Prediction of Adult Height (TW2 Method). New York: Academic Press, 1975.
  90. Vejvoda М, Grant ОВ: Oiscordant bone maturation of the hand in children with precocious puberty and congenital adrenal hyperplasia. Acta Paediatr 1981;70:903-905.
  91. Жуковский М.А., Бухман А.И. Сроки окостенения скелета кисти и дистального отдела предплечья у детей и подростков г. Москвы в кн. Детская эндокринология: Руководство для врачей. М.: Медицина, 1995, с. 40
  92. Greulich W, Pyle S. Radiographic Atlas of Skeletal Oevelopment of the Hand and Wrist. Stanford, Calif: Stanford University Press, 1999.
  93. Bull RK, Edwards PD, Kemp РМ, Fry S, Hughes IA. Bone age assessment: а large scale comparison of the Greulich and Pyle, and Tanner and Whitehouse (TW2) methods. Arch Ois Child 1999;81(2):172173.
  94. . Fahmy JL, Kaminsky СК, Kaufinan F, Nelson МО, Parisi МТ: The radiological approach to precocious puberty. Br J Radiol 2000;73:560.
  95. Martin OD, Stahl К, Schweizer R, Thodberg НН, Ranke МВ: Validation of BoneXpert in children with precocious puberty. Horm Res 2008;70(suppl 1):73.
  96. Breen МА, Tsai А, Stamm А, Кleinman РК. Bone age assessment practices in infants and older cl1ildren among Society for Pediatric Radiology members. Pediatr Radiol 2016;46(9):1269-1274.
  97. Хи Y-Q, Li G-M, Li У . Advanced bone age as an indicator facilitates the diagnosis of precocious puberty. J Pediatr (Rio J). 2018 Feb;94(1):69-75.
  98. Martin 00, Wit JM, Hochberg Z, van Rijn RR, Fricke О, Werther G, et al. The use of bone age in clinical practicepart 2. Horm Res Paediatr. 2011;76(1):106.
  99. Mogensen SS, Aksglaede L, Mouritsen А, S0rensen К, Main КМ, Gideon Р, et al. Pathological and incidental findings on brain MRI in а single-center study of 229 consecutive girls with early or precocious puberty. PLoS One. 2012; 7(1):е29829.
  100. Lee J, Kim J, Yang А, Cho SY, Jin DK. Etiological trends in male central precocious uberty. Ann Pediatr Endocrinol Metab.2018 Jun; 23(2): 7580.
  101. 1О1. aul В. Kaplowitz Оо 6-8 year old girls with central precocious puberty need routine brain imaging? Int J Pediatr Endoc rinol; 2016: 9. doi: 10.1186 /s13633-0 16-0027-5
  102. Kim I, Young R, Scully R. Leydig cell Tumors of the testis. А clinicopathological analysis of 40 cases and review ofthe literature. Ат J Surg Path. 1985;9:177-192.
  103. Cecchetto G, Alaggio R, Bisogno G, et al. Sex cord-stromal tumors of the testis in children. А clinicopathologic report from the Italian TREP project. J Pediatr Surg. 2010;45:1868 1873.
  104. Wendt S, Shelso J, Wright К, Furman W. eoplastic causes of abnormal puberty. Pediatr Вlood Cancer. 2014;61(4):664-671. doi:10.1002/рЬс.24825
  105. Alagha Е, Kafi SE, Shazly МА, Al-Agha А. Precocious Puberty Associated with Testicular Hormone-secreting Leydig Cell Tumor. Cureus. 2019;11(12):е6441. PuЬ!ished 2019 Dec 22. doi:1О.77 59 / c ureus.644 l
  106. Jakubowska А, Grajewska-Ferens М, Brzewski М, Sopylo В. Ussefulnes of imaging techniques in the diagnostics of precocious puberty in boys. Pol J Radiol . 2011;76(4):21-27 .
  107. Haber НР, Wollmann НА, Ranke МВ. Pelvic ultrasonography:early differentiation between isolated premature thelarche and central precocious puberty. Eur J Pediatr . 1995;154(3): 182186
  108. Eksioglu AS, Yilmaz S, Cetinkaya S, Cinar G, Yildiz УТ, Aycan Z. Value of pelvic sonography in the diagnosis of various forms of precocious puberty in girls. J Clin Ultrasound JC U. 2013 Feb;41(2):84-93.
  109. Sathasi vam А, Rosenberg НК, Shapiro S, Wang Н, Rapaport R. Pelvic ultraso nography in the evaluation of central precocious puberty: comparison with leuprolide stimulation test. J Pediatr. 2011 Sep;159(3):490 5.
  110. 11О. Badouraki М, Christoforidis А, Economou l, Dimit riadis AS, Katzos G. Evaluation of pelvic ultrasonography in the diagnosis and differentiation of various forms of sexual precocity in girls. Ultrasound Obstet Gynecol. 2008 Nov;32(6):8 l 9-27. doi: 10.100 2/uog.6148.
  111. 111. Kang Е, Cho JH, Choi J-H, Уоо H-W. Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty. Ann Pediatr Endocrinol Metab. 2016 Sep;2 l (3):136-42.
  112. 112 . Schneider ОТ, Terenziani М, Cecchetto G. Schneider DT, Brecht IВ, Olson ТА, Ferrari А, et а\., editors. Gonadal and extragonadal germ cell tumors, sex cord stromal and гаге gonadal tumors. Chap 39. Rare Tumors in Children and Adolescents. Germany: Springer Berlin Heidelberg ; 2102. 327-402. Parida L. Nonurological malignancies in children. J lndian Assoc Pediatr Surg 2014;19:3 17.
  113. Lin Х, Wu D, Zheng N, Xia Q, Han У. Gonadal germ cell tumors in children. Medicine (Baltimore). 2017 Jun 30 [cited 2019 Dec 2];96(26).
  114. Mulder RL, Кremer LCM, van Santen НМ, Ket JL, van Trotsenburg ASP, Koning ССЕ, et а!. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: а systematic review. Cancer Treat Rev. 2009 Nov;35(7):61632.
  115. van Iersel L, Li Z, Srivasta va DK, Brinkшan ТМ, Bjomard KL, Wilson C L, et al. HypothalamicPituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6101-15.
  116. Javaid МК, Воусе А, Appelman -Dijkstra N, Ong J, Defabianis Р, Offiah А, et а\. Best practice management guidelines for fibrous dysplasia/McCune-Alb right syndrome: а consensus statement from the FD/MAS intemational consortium. Orphanet J Rare Dis. 2019 Jun 13 ; 14(1):139. 11 8. Cos tin, G., Kaufi11an, F. HYPOP IТUIТARlSM А D PRECOCIOUS PUBERTY (РР). Pedia1t·Res 18, 166 ( 1 98 4 ). https: //doi.org/10.1203 /00006450-198404001 -00437
  117.  
  118. Darzy КН, Shalet SM. Hypopituitarisш fol\owing radiotl1erapy. Pituitar y. 2009;12(1):40-50. doi: 10 . 1007 /s1110 2-008-0088-4. PMID: 1827084 4.
  119. Darzy, К . Radiat io n-induced hypopituitaгism afteг cancer therapy: wlю, how and wheп to test. Nat R,,e Endoainol 5, 8899 (2009). https://doi.o rg/10 .103 8/ncp eпdшet 1051
  120.  
  121. Bangalore Krishna К, Fuqua JS, Rogol АО, Kleiп КО, Popovic J, Houk СР, et al. Use of Go11adotropi11-Releasi11g Нопnопе Aпalogs iп Childreп: Update Ьу ап Iпtemational Coпsortium. Honn Res Paediatr. 2019;91(6):3 5772.
  122. 122 . Постановление Правительства РФ от 26.04.2012 N 403 (ред. от 20.11.2018) "О порядке ведения Федерального регистра лиц, страдающих жизнеугрожающими и хроническими прогрессирующими редкими (орфан ными) заболеваниями, приводящими к сокращению продолжительности жизни граждан или их инвалидности, и его регионального сегмента".
  123. Lazar L, Padoa А, Phillip М. Growth pattem апd fiпal height after cessation of gonadotropinsuppressive therapy iп girls with central sexual precocity. J Clin Endocrinol Metab. 2007 Sep;92(9):34839.
  124. Parker KL, Baens-Bailon RG, Lee РА. Depot leuprolide acetate dosage for sexual precocity. J Clin Endocrinol Metab 1991 ; 73: 50-2
  125. Partsch CJ, von Buren Е, Braпd М, et al. Efficacy of the subcutaneous refoпnulated triptorelin depot in children with central precocious puberty. Acta Paediatr. 199 8 Dec ;87( 12):1240-4.
  126. 126 . Tato L, Savage МО, Antoniazzi F, et а!. Optimal therapy of pubertal disorders in precocious/early pube rty. J Pediatr Endocriпol Metab 200 l; 14 Suppl. 2:985-95
  127. Antoniazzi F, Zarnboni G. Central precocious puberty: current treatment options. Paediatr Drugs. 2004;6(4):211 3 1.
  128. Yilmaz GC, Kara С, Bitkin ЕС, Aydin НМ. Comparisoп ofTriptorelin Versus Leuprolide in Treatment of Girls with Central Precocious Puberty. In European Society for Paediatric Endocrinology; 2016 [cited 2019 Dec 9]. AvailaЫe from: http://abstracts.eurospe.o rg/hrp/0086/hrp0086p2-p778
  129. Lahlou N, Carel JC, Chaussain JL, Roger М. Phaпnacokinetics and phannacodynamics of GnRH agonists: clinical iшplications in pediatrics. J Pediatr Endocrinol Metab JPEM. 2000 Jul;13 Suppl 1:72337.
  130. 130 . Boepple РА, Mansfield MJ, Wiennan МЕ, Rudlin CR, Bode НН, Crigler JF, et al. Use of а potent, long actiпg agonist of gonadotropin-releasiпg hoпnone in the treatment of precocious puberty. Endocr Rev. 1986 Feb;7(1): 2433.
  131. Cook JS, Doty KL, Conn РМ, Hansen JR. Assessrnent of depot leuprolide acetate dose-adequacy for central precocious puberty. J Clin Endocrinol Metab. 1992 Мау;74(5):1206-9
  132. Carel JC, Lahlou N, Guazzarotti L, Joubert-Collin М, Roger М, Colle М, Chaussain JL. Eur J Endocrinol. Treatment of central precocious puberty with depot leuprorelin . French Leuprorelin Trial Group 1995 Jun; l32(6):699-704
  133. 133 . Lawson ML l, Cohen N. А single sarnple subcutaneou s luteinizing horrnone (LH)-releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists. J Clin Endocrinol Metab. 1999 Dec;84(12):4536-40.
  134. Brito VN l, Latronico АС, Arnhold IJ, Mendonca ВВ. J Clin Endocrinol Metab. 2004 Sep;89(9):4338-42. А single luteinizing horrnone deterrnination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin -dependent precocious puberty in girls .
  135. Carel JC, Вlumberg J, Seyrnour С, Adarnsbaum С, Lahlou N; Triptorelin 3-month СРР Study Group.Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. Eur J Endocrinol. 2006 Jan;154(1):119 -24.
  136. Badaru Al, Wilson ОМ, Bachrach LK, Fechner Р, Gandrud LM, Durham Е, Wintergerst К, Chi С, Кlein КО, Neely ЕК. Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty. J Clin Endocrinol Metab. 2006 Мау;91(5):1862-7. Epub 2006 Jan 31.
  137. Latronico АС, Brito VN, Carel JC. Causes, diagnosis, and treatrnent of central precocious puberty. Lancet Diabetes Endocrinol. 2016 Mar;4(3):265 -274. doi: I0.10 16/S2213 -8587(15)00380-0. Epub 2016 Feb 4.
  138. Bangalore Кrishna, Kanthi & Fuqua, John S & Rogol, Alan & Klein, Karen О & Popovic, Jadranka & Houk, Christopher & Charrnandari, Evangelia & Lee, Peter А. (2019). Use of Gonadotropin-Releasing Honnone Analogs in Children: Update Ьу an Intemational Consortium. Horrnone Researcl1 in Paediatrics. 91. 1-16. 10 . 1159 /00 050 1336 .
  139. Фе де рал ьн ые клинические реко мендации (протоколы) по ведению детей Ф32 с эндокринными заболева ниями [ин тернет] / под ред. И.И. Дедова, В.А. Петерковой. М.: Практика, 2014. С. 277294.
  140. Приказ Министерства зд равоо хранения и социального развития Российской Феде рации (Минздравсоцразвития России) от 5 мая 2012 г. N 502н г. Москва "Об утверждении порядка создания и деятел ьности врачебной комиссии медицинской организации"
  141. Mieszczak J, Lowe ES, Plourde Р, et al. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 2008;93(7):2751е4. N.G. Haddad, Е.А. Eugster / Best Practice & Research Clinical Endocrinology & Metabolism 33 (2019) 101273 13
  142. 14 2. Estrada А, Воусе АМ, Brillante ВА, et al. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome. Eur J Endocrinol 2016;175(5):477е83.
  143. Feuillan Р, Calis К, Hill S, et al. Letrozole treatment of precocious puberty in girls with the McCune -Albright syndrome: а pilot study. J Clin Endocrinol Metab 2007;92(6):2 l 00е6.
  144. Eugster ЕА, RuЬin SD, Reiter ЕО, et al. Tamoxifen treatment for precocious puberty in McCune Albright syndrome: а multicenter trial. J Pediatr 2003;143(1):60е6.
  145. de GBPC, Kuperman Н, Cabral de Menezes-Filho Н, et al. Tamoxifen improves final height prediction in girls with McCune-Alb right syndrome: а long follow-up. Hormone Res Paediatrics 2015;84(3):184е9.
  146. Sims ЕК, Gamett S, Guzman F, et al. Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome. Int J Pediatr Endocrinol 2012;2012(1):26.
  147. Кreher NC, Pescovitz ОН, Delameter Р, et al. Treatment of familial male-limited precocious puberty with Ьicalutamide and anastrozole. J Pediatr 2006;149(3):416е20.
  148. ЕО Reiter et al. Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: а phase II, open-label pilot study (ВАТТ) J Pediatr Endocrinol Metab (201О) PMID: 21158211 DOI: 10.15 15/jpem.2010.161
  149. Tessaris D, Matarazzo Р, Mussa А, et al. ComЫned treatment with Ьicalutamide and anastrozole in а young Ьоу with peripheral precocious puberty due to McCune-Albright Syndrome. Endocr J 2012;59(2): l l le7.
  150. Guven А, Nurcan Cebeci А, Hancili S. Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated Ьу central precocious puberty. Hormones (Basel) 2015;14( 2):265е71.
  151. Pescovitz ОН, Comite F, Cassorla F, et al. True precocious puberty complicating congenital adrenal hyperplasia: treatment with а luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab 1984;58(5):857е61.
  152. Brito VN, Spinola-Castro АМ, Kochi С, Kopacek С, Silva РС, Guerra-Junior G. Central precocious puberty: revisiting the diagnosis and therapeutic management. Arch Endocrinol Metab. 2016 Apr;60(2):163 -72. doi: 1О.1590 /2359-3997000000144.
  153. Breen JL, Maxson WS. Ovarian tumors in children and adolescent s. Clinical Obstetrics Gynecol l 977;20(3):607e23
  154. Mayer SK, Oligny LL, Deal С, et al. Childhood adrenocortical tumors: case series and reevaluation of prognosisa 24-year experi e nce. J Pediatr Surg l997;32(6):91l e5.
  155. Cheville JC, Sebo ТJ, Lager DJ, et al. Leydig cell tшnor of the testis: а clinicopathologic, DNA content, and МIВ-1 comparison of nonшetastasizing and metastasizing tumors. Am J Surg Pathol 1998 ;22( 11):1361е7
  156. Michalkiewicz Е, Sandrini R, Figueiredo В, et al. Clinical and outcome characteristics of children with adrenocortical tumors: а report from the Intemational Pediatric Adrenocortical Tumor Registry. J Clin Oncol Official J Ат Soc Clinical Oncol 2004;22(5):838е45.
  157. Hughes IA, Houk С, Ahmed SF, et al. Consensus statement on the management of intersex disor ders. J Ped Urol. 2006;2:148.
  158. 158 . Murray MJ, et al. Consensus on the management of intracranial germ-cell tumo urs. Lancet Oncol. 2015. PMID: 26370356 Review
  159. Мартыш Н.С., Киселева И.А. Корреляция данных эхо rрафическо rо обследования внутренних органов с физическим и половым развитием здоровых детей. //Нарушение репродуктивной системы в периоде детстве и полового созревания.-М.,1986.-С.40-51.
  160. Клинические рекомен дации «Экстракраниальные rерминогенно-клеточные опухоли у детей» разработанные Национальным обществом детских гематологов, онкологов. Год утверждения 2020. https://cr.minzdrav.gov.ru/schema/69_1#doc _Ь

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу